The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Consulting or Advisory Role - Argos Therapeutics
Travel, Accommodations, Expenses - Merck
Sporadic angiomyolipomas (AMLs) growth kinetics while on everolimus (SAGE).
 
Daniel M. Geynisman
Consulting or Advisory Role - AstraZeneca; Exelixis; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Merck (Inst)
 
Brian T. Kadow
No Relationships to Disclose
 
Brian M. Shuch
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - Astellas Medivation; Ferring
 
Surena F. Matin
Honoraria - C-SATS; Peloton Therapeutics; Taris BioMedical; Urogen pharma
Consulting or Advisory Role - C-SATS; Peloton Therapeutics; Theracoat; Urogen pharma
Research Funding - AT&T
 
Edward Rampersaud
No Relationships to Disclose
 
Daniel McClean
No Relationships to Disclose
 
Barton N Milestone
No Relationships to Disclose
 
Elizabeth R. Plimack
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Genentech/Roche; Horizon Pharma; Incyte; Inovio Pharmaceuticals; Janssen; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst); US Patent No: 15/226,474 files on 7/1/15 (Inst)
 
Matthew R. Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - EMD Serono; Horizon Pharma; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Horizon Pharma (Inst); Pfizer (Inst)
Other Relationship - Association of Community Cancer Centers (ACCC)
 
Alexander Kutikov
Employment - Visible Health
Leadership - Visible Health
Stock and Other Ownership Interests - Visible Health
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Genomic Health
 
Marc C. Smaldone
No Relationships to Disclose
 
David Chen
No Relationships to Disclose
 
Rosalia Viterbo
No Relationships to Disclose
 
Shreyas Joshi
No Relationships to Disclose
 
Richard E. Greenberg
No Relationships to Disclose
 
Lois Malizzia
No Relationships to Disclose
 
Thomas McGowan
No Relationships to Disclose
 
Eric A. Ross
No Relationships to Disclose
 
Robert Uzzo
Consulting or Advisory Role - Genentech/Roche; Johnson & Johnson; Pfizer
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis